Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy
Clinical trial NCT03629782 · COMPLETED
Trial details
- NCT number
- NCT03629782
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-04-26
- Primary completion
- 2020-07-31
- Enrollment
- 1032
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.